Stock Scorer

Cardinal Health Inc (CAH) · Peers

Cardinal Health against the 10 other companies here in its SEC industry, Wholesale-Drugs, Proprietaries & Druggists' Sundries. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 11, highest first.

Measure by measure

MeasureCAHPeer medianRank
Market value $59.09B median $27.02M 3 of 11
P/E 34.5× median 25.5× 2 of 4
Forward P/E 20.2× median 12.7× 2 of 5
EV/EBITDA 17.6× median 16.8× 3 of 6
P/S 0.2× median 0.3× 7 of 11
FCF yield 7.7% median 4.9% 4 of 11
Dividend yield 0.8% median 0.7% 2 of 4
Gross margin 3.8% median 11.1% 8 of 11
Operating margin 1.0% median -12.8% 3 of 11
Net margin 0.7% median -24.4% 3 of 11
ROIC 218.0% median -0.0% 2 of 9
Revenue growth (4y, yearly) 8.8% median -1.7% 3 of 8
Net debt / EBITDA 1.1× median 2.3× 4 of 6
Current ratio 0.9× median 1.0× 8 of 11
Stock pay / revenue 0.1% median 2.0% 8 of 11
Share count change -2.1% median 38.6% 8 of 10

Green where Cardinal Health is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.

The peers, largest first

CompanyMarket valueP/EROICScore
CAHCardinal Health Inc $59.09B P/E 34.5× 218.0% 5.9
MCKMcKesson Corporation $117.15B P/E 25.5× 998.3% 6.0
CORCencora, Inc. $65.06B P/E 41.9× 19.6% 5.1
HLFHerbalife Ltd. $1.53B P/E 9.3× 32.8% 5.7
NUSNU Skin Enterprises, Inc. $250.20M P/E – -1.4% 4.7
COSMCosmos Health Inc. $33.34M P/E – -65.7% 4.0
HWHHWH International Inc. $20.71M P/E – -204.9% 2.8
MEDSDataMeds AI, Inc. $8.05M P/E – -191.1% 2.0
HKPDCellyan Biotechnology Co., Ltd $4.65M P/E – 1.4% 4.8
NASCCan B Corp $981,536 P/E – – 3.3
STEKStemtech Corp $299,703 P/E – – 3.1

The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.